Log In
Print this Print this

raxibacumab (formerly ABthrax)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHuman mAb against Bacillus anthracis protective antigen
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentApproved
Standard IndicationAnthrax
Indication DetailsTreat anthrax infection
Regulatory Designation U.S. - Orphan Drug (Treat anthrax infection)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today